Cancer Res Treat.  2018 Jul;50(3):729-737. 10.4143/crt.2017.166.

Nationwide Trends in the Incidence of Melanoma and Non-melanoma Skin Cancers from 1999 to 2014 in South Korea

• Oh CM
• Cho H
• Won YJ
• Kong HJ
• Roh YH
• Jeong KH
• Jung KW

• KMID: 2417862
• DOI: http://doi.org/10.4143/crt.2017.166

Abstract

PURPOSE
This descriptive study was aimed to examine trends in the incidence of melanoma and nonmelanoma in South Korea.
MATERIALS AND METHODS
The nationwide incidence data for melanoma and non-melanoma skin cancer was obtained from the Korea Central Cancer Registry. Age-standardized rates were calculated and analyzed, using a Joinpoint regression model.
RESULTS
The incidence of basal cell carcinoma has increased dramatically both in men (average annual percentage change [AAPC], 8.0 [95% confidence interval (CI), 6.0 to 10.1]) and women (AAPC, 9.0 [95% CI, 7.5 to 10.4]). Squamous cell carcinoma has also steadily increased both in men (AAPC, 3.3 [95% CI, 2.6 to 4.0]) and women (AAPC, 6.8 [95% CI, 5.3 to 8.4]). Cutaneous melanoma increased continuously from 1999 to 2014 inwomen (AAPC, 3.5 [95% CI, 2.4 to 4.6]), whilst rapidly increasing in men until 2005 (APC, 7.9 [95% CI, 2.4 to 13.7]) after which no increase has been observed (APC, -0.2 [95% CI, -2.3 to 2.0]).
CONCLUSION
The incidence rates of melanoma and non-melanoma skin cancer have increased over the past years, with the exception of melanoma in men. Further studies are required to investigate the reasons for the increased incidence of these skin cancers in South Korea.

Keyword

Incidence; Trend; Melanoma; Squamous cell carcinoma; Basal cell carcinoma

MeSH Terms

Carcinoma, Basal Cell
Carcinoma, Squamous Cell
Female
Humans
Incidence*
Korea*
Male
Melanoma*
Skin Neoplasms*
Skin*

Figure

• 

  Fig. 1. (A) Trends in age-standardized incidence rates for melanoma, basal cell carcinoma, and squamous cell carcinoma in Korean men, 1999-2014. (B) Trends in age-standardized incidence rates for melanoma, basal cell carcinoma and squamous cell carcinoma in Korean women, 1999-2014. APC, anuual percent change. The age-standardized incidence rates are presented as incidence cases per 100,000 people using Segi’s world standard population as standard population. Joinpoint regression analysis was used to determine whether there were significant changes in trends in age-standardized incidence rates for the period between 1999 and 2014. *p < 0.05.

Reference

References

1. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017; 67:7–30.

2. Miller AJ, Mihm MC Jr. Melanoma. N Engl J Med. 2006; 355:51–65.

3. Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012; 166:1069–80.

4. Erdmann F, Lortet-Tieulent J, Schuz J, Zeeb H, Greinert R, Breitbart EW, et al. International trends in the incidence of malignant melanoma 1953-2008: are recent generations at higher or lower risk? Int J Cancer. 2013; 132:385–400.

5. Koh D, Wang H, Lee J, Chia KS, Lee HP, Goh CL. Basal cell carcinoma, squamous cell carcinoma and melanoma of the skin: analysis of the Singapore Cancer Registry data 1968-97. Br J Dermatol. 2003; 148:1161–6.

6. Kim GK, Del Rosso JQ, Bellew S. Skin cancer in asians: part 1: nonmelanoma skin cancer. J Clin Aesthet Dermatol. 2009; 2:39–42.

7. CDC’s National Program of Cancer Registries and National Cancer Institute’s Surveillance, Epidemiology, and End Results program [Internet]. Atlanta, GA: Centers for Disease Control and Prevention;2017. [cited 2017 Jun 1]. Available from: https://www.cdc.gov/cancer/skin/statistics/race.htm.

8. Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Altekruse SF, et al. SEER Cancer Statistics Review, 1975-2013 [Internet]. Bethesda, MD: National Cancer Institute;2016. [cited 2017 Jun 1]. Available from: http://seer.cancer.gov/csr/1975_2013/.

9. Glazer AM, Winkelmann RR, Farberg AS, Rigel DS. Analysis of trends in US melanoma incidence and mortality. JAMA Dermatol. 2016; Dec. 21. [Epub]. https://doi.org/10.1001/jamadermatol.2016.4512.

10. Demers AA, Nugent Z, Mihalcioiu C, Wiseman MC, Kliewer EV. Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian population. J Am Acad Dermatol. 2005; 53:320–8.

11. Birch-Johansen F, Jensen A, Mortensen L, Olesen AB, Kjaer SK. Trends in the incidence of nonmelanoma skin cancer in Denmark 1978-2007: rapid incidence increase among young Danish women. Int J Cancer. 2010; 127:2190–8.

12. Sng J, Koh D, Siong WC, Choo TB. Skin cancer trends among Asians living in Singapore from 1968 to 2006. J Am Acad Dermatol. 2009; 61:426–32.

13. Stern RS. The mysteries of geographic variability in nonmelanoma skin cancer incidence. Arch Dermatol. 1999; 135:843–4.

14. Oh CM, Won YJ, Jung KW, Kong HJ, Cho H, Lee JK, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2013. Cancer Res Treat. 2016; 48:436–50.

15. Shin HR, Won YJ, Jung KW, Kong HJ, Yim SH, Lee JK, et al. Nationwide cancer incidence in Korea, 1999~2001; first result using the national cancer incidence database. Cancer Res Treat. 2005; 37:325–31.

16. World Health Organization. International statistical classification of diseases and related health problems. 10th rev. Geneva: World Health Organization;1994.

17. Egevad L, Heanue M, Berney D, Fleming K, Ferlay J. Histological groups. In : Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, editors. Cancer incidence in five continents, Vol. X (electronic version). Lyon: IARC;2013. p. 61–6.

18. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al. International classification of diseases for oncology. 3rd ed. Geneva: World Health Organization;2000.

19. Segi M. Cancer mortality for selected sites in 24 countries (1950-57). Sendai: Tohoku University of Medicine;1960.

20. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000; 19:335–51.

21. Makredes M, Hui SK, Kimball AB. Melanoma in Hong Kong between 1983 and 2002: a decreasing trend in incidence observed in a complex socio-political and economic setting. Melanoma Res. 2010; 20:427–30.

22. Ichihashi M, Naruse K, Harada S, Nagano T, Nakamura T, Suzuki T, et al. Trends in nonmelanoma skin cancer in Japan. Grabe C, Schmitz S, Orfanos CE. Skin cancer: basic science, clinical research and treatment. Berlin: Springer;1995. p. 263–73.

23. Nikolaou V, Stratigos AJ. Emerging trends in the epidemiology of melanoma. Br J Dermatol. 2014; 170:11–9.

24. Jemal A, Saraiya M, Patel P, Cherala SS, Barnholtz-Sloan J, Kim J, et al. Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006. J Am Acad Dermatol. 2011; 65(5 Suppl 1):S17–25. e1-3.

25. Helvind NM, Holmich LR, Smith S, Glud M, Andersen KK, Dalton SO, et al. Incidence of in situ and invasive melanoma in Denmark from 1985 through 2012: a national database study of 24,059 melanoma cases. JAMA Dermatol. 2015; 151:1087–95.

26. Park SJ, Oh CM, Kim BW, Woo SJ, Cho H, Park KH. Nationwide incidence of ocular melanoma in South Korea by using the national cancer registry database (1999-2011) incidence of ocular melanoma and subtype in Korea. Invest Ophthalmol Vis Sci. 2015; 56:4719–24.

27. Suh M, Choi KS, Park B, Lee YY, Jun JK, Lee DH, et al. Trends in cancer screening rates among Korean men and women: results of the Korean national cancer screening survey, 2004-2013. Cancer Res Treat. 2016; 48:1–10.

28. Zloto O, Pe'er J, Frenkel S. Gender differences in clinical presentation and prognosis of uveal melanoma. Invest Ophthalmol Vis Sci. 2013; 54:652–6.

29. Lee MW, Koh JK, Kwon KS, Kim NI, Kim SW, Kim SN, et al. Clinical and histopathological study of cutaneous melanoma in Korea. Korean J Dermatol. 2003; 41:43–7.

30. Reinau D, Surber C, Jick SS, Meier CR. Epidemiology of basal cell carcinoma in the United Kingdom: incidence, lifestyle factors, and comorbidities. Br J Cancer. 2014; 111:203–6.